The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Betnovate Scalp Application 0.1% w/v Cutaneous Solution



GlaxoSmithKline (Ireland) LimitedPA1077/001/003

Main Information

Trade NameBetnovate Scalp Application 0.1% w/v Cutaneous Solution
Active SubstancesBetamethasone
Dosage FormCutaneous solution
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/001/003

Group Information

ATC CodeD07AC Corticosteroids, potent (group III)
D07AC01 betamethasone

Status

License statusAuthorised
Licence Issued05/03/1984
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone.
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back